Skip to main content

Want a detailed portfolio tracker?

Cyclerion Therapeutics (CYCN) P/E (2019 - 2026)

Cyclerion Therapeutics (CYCN) P/E from Jul 1, 2019 to Jul 20, 2026. The TTM Cyclerion Therapeutics (CYCN) P/E is -2.72. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cyclerion Therapeutics (CYCN)

YearP/EChange
2026-2.72+123.78%
2025-1.21-54.10%
2024-2.65+306.86%
2023-0.65+23.35%
2022-0.53-62.15%
2021-1.39+16.01%
2020-1.20+37.52%
2019-0.87N/A

Comparison Cyclerion Therapeutics (CYCN) P/E with competitors

Cyclerion Therapeutics (CYCN) P/E is -2.72.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.16%
ENLVEnlivex Ltd0.07-102.75%
FGENFibroGen Inc0.24-108.83%
CHRSCoherus Biosciences Inc0.85-131.22%
FBIOFortress Biotech Inc0.95-134.92%
ORMPOramed Pharmaceuticals Inc1.50-155.31%
AGENAgenus Inc3.01-210.74%
INVAInnoviva Inc3.15-216.05%
VXRTVaxart Inc3.55-230.62%
CRMDCorMedix Inc3.63-233.51%
CVACCureVac N.V.4.45-263.58%
GLPGGalapagos NV4.86-278.79%
SRPTSarepta Therapeutics Inc4.88-279.64%
ABEOAbeona Therapeutics Inc5.39-298.24%
ABUSArbutus Biopharma Corp5.60-305.89%
ZVRAZevra Therapeutics Inc5.89-316.62%
SPROSpero Therapeutics Inc6.23-329.18%
CGENCompugen Ltd6.31-332.33%
RIGLRigel Pharmaceuticals6.87-352.86%
SLXNSilexion Therapeutics Corp7.30-368.46%
OMEROmeros Corporation9.26-440.68%
AUPHAurinia Pharmaceuticals Inc9.58-452.69%
PLXProtalix BioTherapeutics Inc10.89-500.74%
ACADAcadia Pharmaceuticals Inc11.73-531.56%
TBPHTheravance Biopharma Inc12.26-551.20%
ADMAAdma Biologics Inc12.42-556.94%
HRMYHarmony Biosciences Holdings Inc13.82-608.53%
SABSSAB Biotherapeutics Inc14.14-620.15%
NAGENiagen Bioscience Inc14.82-645.25%
INCYIncyte Corp15.82-682.20%
REGNRegeneron Pharmaceuticals Inc15.86-683.46%
PBYIPuma Biotechnology Inc17.32-737.15%
CPRXCatalyst Pharmaceuticals Inc17.44-741.69%
EXELExelixis Inc17.54-745.33%
TGTXTG Therapeutics Inc18.97-797.87%
MDXGMimedx Group Inc20.55-856.25%
XOMAXOMA Royalty Corp22.87-941.72%
ARGXArgen X SE24.30-994.09%
CTMXCytomX Therapeutics Inc24.82-1013.34%
XOMAOXOMA Royalty Corp25.34-1032.61%
HALOHalozyme Therapeutics Inc25.62-1042.87%
XOMAPXOMA Royalty Corp25.67-1044.58%
VRTXVertex Pharmaceuticals Inc27.99-1130.12%
RPRXRoyalty Pharma plc - Class A28.69-1155.61%
SLNOSoleno Therapeutics Inc29.02-1167.67%
ASNDAscendis Pharma A/S30.09-1207.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1495.04%
APLSApellis Pharmaceuticals Inc39.02-1535.86%
BMRNBiomarin Pharmaceutical Inc42.21-1653.26%
KRYSKrystal Biotech Inc45.34-1768.50%
ONCBeiGene Ltd69.54-2658.87%
PHARPharming Group N.V.75.03-2860.71%
TECHBio-Techne Corp101.96-3851.75%
VCELVericel Corp109.92-4144.76%
ALNYAlnylam Pharmaceuticals Inc117.96-4440.75%
GMABGenmab140.29-5262.26%
TLXTelix Pharmaceuticals Ltd162.15-6066.72%
CORTCorcept Therapeutics Inc212.86-7932.49%